Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Block deal: Goldman Sachs picks stake in this smallcap stock that surged 50% in 6 months
GNG Electronics witnessed a Rs 175 crore block deal as promoter Vidhi Khandelwal sold shares to domestic mutual funds and foreign investors. Institutional interest comes amid optimism over the company’s leadership in the refurbished electronics market and strong growth prospects.
Privi Speciality in Focus: Motilal Oswal Remains Bullish on Strong Growth Story — Check Target Price
The upcoming mergers with Privi Fine Science, Privi BiotechnologiesL and PRIGIV JV with Givaudaare expected to expand Privi's specialty aroma portfolio, which is expected to drive revenue growth, enhance earnings.
Glenmark Pharma Profit Expected To Soar 5x in Two Years, Says Motilal Oswal — Check Target Price
Glenmark Pharma's shares are likely to remain in focus after Motilal Oswal has reiterated its positive stance on the stock.
Cummins India Stock in Focus: Motilal Oswal Bullish on Growth Outlook — Check Target Price
Motilal Oswal expects Cummins overall Ebitda margin to remain strong on a healthy revenue mix despite higher raw material prices, which are currently passed through to clients.
IndiGo shares gain 2% after analyst meet. Why Goldman, Morgan Stanley, others see up to 38% upside?
IndiGo shares witnessed an uptick on Tuesday after its analyst meet, where management outlined strong long-term growth plans driven by rising air travel demand and international expansion. Brokerages including Goldman Sachs, Morgan Stanley, Motilal Oswal and Elara Capital reiterated bullish views, seeing up to 38% upside despite near-term geopolitical and fuel-price risks.
Gabriel India Shares in Focus After Motilal Oswal Initiates Coverage with 'Buy' — Check Target Price, Potential Upside
Consistent dividend payouts reflects Gabriel India's ability to generate and return surplus cash to shareholders across business cycles.
Stocks in news: Bharti Airtel, Vodafone Idea, NLC India, Motilal Oswal, HCL Tech
Indian markets saw a sharp decline on Monday amid global worries and geopolitical tensions. Nifty moved closer to a key support level. Several companies were in focus. NLC India announced an Offer for Sale. Motilal Oswal saw promoter share sales. HCL Tech launched an AI zone with Google Cloud. IRCTC resumed cooking on trains. IGL has a new MD.
Two Adani Group stocks in focus as GQG sells stake in Rs 5,750 crore deal; SBI MF lone buyer
Adani Enterprises and Adani Energy Solutions will be in focus after GQG Partners sold stakes worth about Rs 5,750 crore via block deals, with SBI Mutual Fund buying the shares. The move is seen as portfolio rebalancing following a strong recovery in Adani Group stocks over the past year.
L&T, Cummins, Dixon Among Motilal Oswal's Capital Goods Picks; BEL Tops Defence Bet — Full List Inside
Motilal Oswal remains positive on transmission, data centre, and defense-led capex beneficiaries.
ICICI Bank shares in focus after lender receives Sebi’s warning letter. Here's why
ICICI Bank shares are under scrutiny after Sebi issued a warning for a custodian violation related to FPI fund repatriation. Despite this, the bank stated no material impact on its financials. Meanwhile, Motilal Oswal maintains a 'Buy' rating, citing strong growth prospects and a target price of Rs 1,750.
ET Alpha Wealth Summit: India outperformed emerging markets over a 10-15 year period; market lag is recency bias: Vikas Khemani
Veteran investor Vikas Khemani said concerns over Indian equities stem largely from recency bias, not weakening fundamentals. Speaking at the ET Alpha Wealth Summit, he highlighted India’s strong long-term outperformance versus emerging markets and urged investors to focus on structural growth drivers rather than short-term market volatility.
Alkem Labs sees Rs 930 crore block deal as promoter family entities pare stake; Goldman, Morgan Stanley among key buyers
Alkem Laboratories shares experienced significant block deals totaling Rs 930 crore. Promoter family entities divested shares to a group of domestic mutual funds and foreign institutional investors. This transaction occurred after a strong performance by Alkem Laboratories shares over the past year. The deal highlights continued institutional interest in the pharmaceutical sector.